GBA
ABBV icon

Garrison Bradford & Associates’s AbbVie ABBV Stock Holding History

Garrison Bradford & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,900
Closed -$333K – 105
2014
Q2 		$333K Hold
5,900
– – 0.31% 71
2014
Q1 		$303K Hold
5,900
– – 0.29% 72
2013
Q4 		$312K Buy
5,900
+100
+2% +$4.92K 0.29% 64
2013
Q3 		$259K Hold
5,800
– – 0.27% 74
2013
Q2 		$240K Buy
+5,800
New +$254K 0.26% 76

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Garrison Bradford & Associates's ABBV Position: Q3 2014 in Review

Garrison Bradford & Associates sold out of AbbVie (ABBV) in Q3 2014, closing a stake of 5,900 shares — an estimated $333K sold.

Garrison Bradford & Associates first reported a position in ABBV in Q2 2013 and held it in 5 quarters. The position peaked at $333K in Q2 2014. 1,503 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

  • Garrison Bradford & Associates reported no remaining AbbVie position as of Q3 2014 after selling out during the quarter.
  • Garrison Bradford & Associates sold 5,900 AbbVie shares in Q3 2014, an estimated $333K.
  • Garrison Bradford & Associates first reported a position in AbbVie in Q2 2013 and held it in 5 quarters.
  • Garrison Bradford & Associates's AbbVie position peaked at $333K in Q2 2014.
  • 1,503 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on Garrison Bradford & Associates's 13F filing for Q3 2014, filed 7 Nov 2014.